Genomic landscape of neutrophilic leukemias of ambiguous diagnosis
Haijiao Zhang(Oregon Health & Science University), Jeffrey Tyner(Oregon Health & Science University), Robert P. Searles(Oregon Health & Science University), Rachel Henson(Oregon Health & Science University), Michael W. Deininger(Versiti Blood Center of Wisconsin), Beth Wilmot(Oregon Health & Science University), Marlise R. Luskin(Dana-Farber Cancer Institute), Angela Rofelty, Emily A. Stevens(Cancer Research Institute), Christopher A. Eide(Howard Hughes Medical Institute), Daniel A. Pollyea(University of Colorado Denver), Brian Druker(Oregon Health & Science University), Libbey White(Oregon Health & Science University), Amy Carlos(Oregon Health & Science University), Nicola Long, Chenwei Lin(Zhejiang A & F University), Daniel Bottomly(Oregon Health & Science University), Jason Gotlib(Stanford University), Shannon K. McWeeney(Oregon Health & Science University), Richard M. Stone(Dana-Farber Cancer Institute), Julia E. Maxson(Oregon Health & Science University), Samantha L. Savage, Hein Than(University of Utah), Anna Reister Schultz, Tamara Dunn(Stanford University), Daniel J. DeAngelo(Dana-Farber Cancer Institute), Robert H. Collins(Texas Oncology), David P. Steensma(Harvard University), Vishesh Khanna(Howard Hughes Medical Institute), Bruno C. Medeiros(Stanford Medicine), Kim-Hien T. Dao, Stephen T. Oh(Washington University in St. Louis)
Cited by 84
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia
|New England Journal of Medicine|2002|2k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k